Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: The polymerase (P3D(pol)) as an immunodominant T-cell immunogen

Virus Research

Volumn 56, Issue 2, 1998, Pages 125-133

  Collen, T ^a   Baron, J ^a   Childerstone, A ^a   Corteyn, A ^a   Doel, T R ^a,b   Flint, M ^a,c   Garcia Valcarcel, M ^a,d   Parkhouse, R M E ^a   Ryan, M D ^a,e  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Rhône Merieur   (United Kingdom)

^c UNIVERSITY OF READING   (United Kingdom)

^d British Biotechnology Limited   (United Kingdom)

^e UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Foot and mouth disease virus; RNA dependent RNA polymerase; Serotype cross reactivity; T cell recognition

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; VIRUS PROTEIN;

ANIMAL CELL; CATTLE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALIA; BOS TAURUS; BOVINAE; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 0032143034     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00035-5     Document Type: Article

References (38)

1. Barnett B.C., Graham C.M., Burt D.S., Skehel J.J., Thomas D.B. The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B-cell and T-cell repertoires and their relevance to antigenic drift. Eur. J. Immunol. 19:1989;515-521.
2. Berger H.G., Straub O.C., Ahl R., Tesar M., Marquardt O. Identification of foot-and-mouth disease virus-replication in vaccinated cattle by antibodies to nonstructural virus proteins. Vaccine. 8(3):1990;213-216.
3. Bittle J.L., Houghton R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., Brown F. Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the nucleotide sequence. Nature. 298:1982;30-33.
4. Broekhuijsen M.P., van Rijn J.M.M., Blom A.J.M., Pouwels P.H., Enger-Valk B.E., Brown F., Francis M.J. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals. J. Gen. Virol. 68:1987;3137-3143.
5. Clarke B.E., Newton S.E., Carroll A.R., Francis M.J., Appleyard G., Syred A.D., Highfield P.E., Rowlands D.J., Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature. 330:1987;381-384.
6. Collen T., Doel T.R. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J. Gen. Virol. 71(2):1990;309-315.
7. Collen T., McCullough K.C., Doel T.R. Induction of antibody to foot-and-mouth disease virus in presensitized mouse spleen-cell cultures. J. Virol. 52(2):1984;650-655.
8. Collen T., Dimarchi R., Doel T.R. A T-Cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J. Immunol. 146(2):1991;749-755.
9. Cowan K.M., Graves J.H. A third antigenic component associated with foot-and-mouth disease infection. Virology. 30:1966;528-540.
10. Dawe P.S., Pinto A.A. Antibody responses to type-specific and 'virus-infection-associated' antigens in cattle vaccinated with inactivated polyvalent foot-and-mouth disease virus in North Malawi. Br. Vet. J. 134:1978;504-511.
11. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science. 232(4750):1986;639-641.
12. Fernandez, A.A., Mello, P.A.D., Gomes, I., Rosenberg, F., 1975. The use of virus-infection-associated antigen (VIA) in the detection of cattle exposed to FMDV. Boletin del Centro Panamericano de Fiebre Aftosa 17/18, 17-22.
13. Francis M.J., Hastings G.Z., Syred A.D., McGinn B., Brown F., Rowlands D.J. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature. 330:1987;168-170.
14. Glass E.J., Oliver R.A., Collen T., Doel T.R., DiMarchi R., Spooner R.L. MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology. 74:1991;594-599.
15. Howard C.H.J., Naessens J. Summary of workshop findings for cattle. Vet. Immunol. Immunopathol. 39(1-3):1993;25-48.
16. Kleid D.G., Yansura D., Small B., Dowbenko D., Moore D.M., Grubman M.J., McKercher P.D., Morgan D.O., Robertson B.H., Bachrach H.L. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science. 214(4525):1981;1125-1129.
17. Mackay, D.K.J., Forsyth, M.A., Davies, P.R., Berlinzani, A., Belsham, G.J., Flint, M., Ryan, M.D., 1997. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine. In Press.
18. Mackowiak C., Lang C., Fontaine J., Camand R., Petermann H.G. Relationship between neutralising antibody titre and protection in animals immunised against foot-and-mouth disease. Ann. Inst. Pasteur. 103:1962;252-261.
19. McVicar J.W., Sutmöller P. Foot-and-mouth disease: the agar gel difussion precipitin test for antibody to virus-infection-associated (VIA) antigen as a tool for epizootiological surveys. Am. J. Epidemiol. 92:1970;273-278.
20. Milich D.R., McLachlan A., Thornton G.B., Hughes J.L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T-cell site. Nature. 329:1987;547-549.
21. Morgan D.O., Moore D.M. Protection of cattle and swine against foot-and-mouth disease using biosynthetic vaccines. Am. J. Vet. Res. 51:1990;40-45.
22. Murdin A.D., Doel T.R. Synthetic peptide vaccines against foot-and-mouth disease. 1. Duration of the immune-response and priming in guinea-pigs, rabbits and mice. J. Biol. Standard. 15(1):1987;39-51.
23. Newman J.F.E., Piatti P.G., Gorman B.M., Burrage T.G., Ryan M.D., Flint M., Brown F. Foot-and-mouth-disease virus-particles contain replicase protein 3D. Proc. Nat. Acad. Sci. USA. 91(2):1994;733-737.
24. Noelle R.J., Snow E.C. Cognate interactions between helper T-cells and B-cells. Immunol. Today. 11:1990;361-368.
25. Pay T.W.F., Hingley P.J. Correlation of 140S antigen dose with the serum neutralising antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine. 5:1987;60-64.
26. Pfaff E., Mussgay M., Bohm H.O., Schulz G.E., Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1(7):1982;869-874.
27. Pinto A.A., Garland A.J.M. Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine. J. Hyg. 82:1979;41-50.
28. Pinto A.A., Hedger R.S. The detection of antibody to virus-infection associated (VIA) antigen in various species of African wildlife following natural and experimental infection with foot and mouth disease virus. Arch. Virol. 57:1978;307-314.
29. Russell S.M., Liew F.Y. T-cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature. 280:1979;147-148.
30. Ryan M.D., Belsham G.J., King A.M.Q. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology. 173:1989;35-45.
31. Scherle P.A., Gerhard W. Differential ability of B-cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Pro. Nat. Acad. Sci. USA. 85:1988;4446-4450.
32. Taboga O., Tami C., Carrillo E., Nunez J.I., Rodriguez A., Saiz J.C., Blanco E., Valero M.L., Roig X., Camarero J.A., Andreu D., Mateu M.G., Giralt E., Domingo E., Sobrino F., Palma E.L. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71(4):1997;2606-2614.
33. Van Bekkum, J.G., 1969. Correlation between serum antibody level and protection against challenge with FMD virus. European Commission for the control of foot-and-mouth disease. Meeting of the Standing Technical Committee, 38-40.
34. Van Lierop M.J.C., Nilsson P.R., Wagenaar J.P.A., Van Noort J.M., Campbell J.D.M., Glass E.J., Joosten I., Hensen E.J. The influence of MHC polymorphism on the selection of T-cell determinants of FMDV in cattle. Immunology. 84(1):1995;79-85.
35. Vol'pina O.M., Yu Surovoi A., Ivanov V.T. Protection against viral infection with the aid of synthetic peptides. Biomed. Sci. 1:1990;23-32.
36. Wiesmüller K.-H., Jung G., Hess G. Novel low-molecular weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine. 7:1989;29-33.
37. Yarov A.V., Gelfanov V.M., Grechaninova L.A., Surovoy A.Y., Volpina O.M., Ivanov V.T., Chepurkin A.V., Dryagalin N.N., Ivanyushchenkov V.N. Antigenic structure of foot-and-mouth disease virus. 5. Protection of susceptible animals with the use of a synthetic peptide. Bioorganicheskaya Khimiya. 15(10):1989;1313-1317.
38. Zamorano P., Wigdorovitz A., Chaher M.T., Fernandez F.M., Carrillo C., Marcovecchio F.E., Sadir A.M., Borca M.V. Recognition of B-cell and T-cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01-Campos. Virology. 201(2):1994;383-387.